UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia

European journal of cancer (1990), 2013-03, Vol.49 (4), p.860-867

2013

Volltextzugriff (PDF)

Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy

Annals of oncology, 2012-11, Vol.23 (11), p.2903-2906

2012

Volltextzugriff (PDF)

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

British journal of cancer, 2008-11, Vol.99 (10), p.1644-1650

2008

Volltextzugriff (PDF)

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

JNCI : Journal of the National Cancer Institute, 2001-06, Vol.93 (12), p.913-920

2001

Volltextzugriff (PDF)

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1465-1472

2012

Volltextzugriff (PDF)

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

European journal of cancer (1990), 2009-01, Vol.45 (1), p.74-81

2009

Volltextzugriff (PDF)

Independent and functional validation of a multi-tumour-type proliferation signature

British journal of cancer, 2012-07, Vol.107 (3), p.508-515

2012

Volltextzugriff (PDF)

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (2), p.116-128

2002

Volltextzugriff (PDF)

Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies

The International journal of biological markers, 2007-07, Vol.22 (3), p.167-171

2007

Volltextzugriff (PDF)

Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease

The International journal of biological markers, 2006, Vol.21 (1), p.45-49

2006

Volltextzugriff (PDF)

Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids

Antimicrobial Agents and Chemotherapy, 1992-12, Vol.36 (12), p.2785-2789

1992

Volltextzugriff (PDF)

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1825-1835

2013

Volltextzugriff (PDF)

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

Clinical chemistry (Baltimore, Md.), 2010-10, Vol.56 (10), p.1570-1579

2010

Volltextzugriff (PDF)

TRPM7 Is Required for Breast Tumor Cell Metastasis

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.4250-4261

2012

Volltextzugriff (PDF)

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Journal of clinical oncology, 2006-04, Vol.24 (11), p.1665-1671

2006

Volltextzugriff (PDF)

High Prevalence of Central Adrenal Insufficiency in Patients with Prader-Willi Syndrome

The journal of clinical endocrinology and metabolism, 2008-05, Vol.93 (5), p.1649-1654

2008

Volltextzugriff (PDF)

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Critical reviews in oncology/hematology, 2012-11, Vol.84 (2), p.252-260

2012

Volltextzugriff (PDF)

Molecular profiling of platinum resistant ovarian cancer

International journal of cancer, 2006-04, Vol.118 (8), p.1963-1971

2006

Volltextzugriff (PDF)

Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach

Investigational new drugs, 2013-08, Vol.31 (4), p.881-890

2013

Volltextzugriff (PDF)

Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor Binding

The American journal of pathology, 2007-10, Vol.171 (4), p.1324-1333

2007

Volltextzugriff (PDF)

The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer

European journal of clinical investigation, 2010-07, Vol.40 (7), p.591-599

2010

Volltextzugriff (PDF)

Serum vascular endothelial growth factor: a prognostic factor in cervical cancer

Journal of cancer research and clinical oncology, 2009-02, Vol.135 (2), p.283-290

2009

Volltextzugriff (PDF)

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer

International journal of cancer, 2008-10, Vol.123 (8), p.1848-1853

2008

Volltextzugriff (PDF)

Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles

Obstetrics and gynecology (New York. 1953), 2009-02, Vol.113 (2 Pt 1), p.326-331

2009

Volltextzugriff (PDF)

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors

Journal of cancer research and clinical oncology, 2010-05, Vol.136 (5), p.771-778

2010

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaMedical Sciences

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(38)
Life Sciences & Biomedicine
(38)
Humans
(32)
Female
(30)
Oncology
(25)
Tumors
(22)
Gynecology. Andrology. Obstetrics
(19)
Adult
(15)
Middle Aged
(15)
Pharmacology. Drug Treatments
(12)
Prognosis
(10)
Aged
(9)
Female Genital Diseases
(9)
Animals
(7)
Antineoplastic Agents
(7)
Mice
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Breast Neoplasms - Pathology
(6)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia

Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

Independent and functional validation of a multi-tumour-type proliferation signature

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies

Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease

Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

TRPM7 Is Required for Breast Tumor Cell Metastasis

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

High Prevalence of Central Adrenal Insufficiency in Patients with Prader-Willi Syndrome

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Molecular profiling of platinum resistant ovarian cancer

Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach

Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor Binding

The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer

Serum vascular endothelial growth factor: a prognostic factor in cervical cancer

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer

Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors

Aktive Filter

Suchergebnisse filtern